Business Description
Taiwan Bio Therapeutics Co Ltd
ISIN : TW0006892003
Description
Taiwan Bio Therapeutics Co Ltd is a regenerative medicine company specializing in the development of new cell medicines. It provides cell product process development and foundry (CDMO/CMO) services.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.67 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.3 | |||||
| Debt-to-EBITDA | -1.87 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 5.35 | |||||
| Beneish M-Score | 0.04 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 8.8 | |||||
| 3-Year EPS without NRI Growth Rate | -1.4 | |||||
| 3-Year FCF Growth Rate | 8 | |||||
| 3-Year Book Growth Rate | 12.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.69 | |||||
| 9-Day RSI | 25.04 | |||||
| 14-Day RSI | 31.2 | |||||
| 6-1 Month Momentum % | 44.12 | |||||
| 12-1 Month Momentum % | 54.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.53 | |||||
| Quick Ratio | 7.67 | |||||
| Cash Ratio | 6.99 | |||||
| Days Inventory | 829.15 | |||||
| Days Sales Outstanding | 33.45 | |||||
| Days Payable | 122.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -86.4 | |||||
| Shareholder Yield % | -11.84 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 80.08 | |||||
| Operating Margin % | -228.38 | |||||
| Net Margin % | -226.62 | |||||
| FCF Margin % | -355.25 | |||||
| ROE % | -31.07 | |||||
| ROA % | -21.42 | |||||
| ROIC % | -35.08 | |||||
| 3-Year ROIIC % | -35.73 | |||||
| ROC (Joel Greenblatt) % | -40.94 | |||||
| ROCE % | -22.25 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 27.34 | |||||
| PB Ratio | 3.62 | |||||
| Price-to-Tangible-Book | 4.05 | |||||
| EV-to-EBIT | -13.59 | |||||
| EV-to-EBITDA | -21.58 | |||||
| EV-to-Revenue | 30.08 | |||||
| EV-to-FCF | -8.65 | |||||
| Price-to-Net-Current-Asset-Value | 15.05 | |||||
| Price-to-Net-Cash | 27.69 | |||||
| Earnings Yield (Greenblatt) % | -7.36 | |||||
| FCF Yield % | -11.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Taiwan Bio Therapeutics Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 100.802 | ||
| EPS (TTM) (NT$) | -3.473 | ||
| Beta | 0 | ||
| Volatility % | 24.28 | ||
| 14-Day RSI | 31.2 | ||
| 14-Day ATR (NT$) | 1.569686 | ||
| 20-Day SMA (NT$) | 46.535 | ||
| 12-1 Month Momentum % | 54.6 | ||
| 52-Week Range (NT$) | 30.997716 - 60.1 | ||
| Shares Outstanding (Mil) | 74.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Taiwan Bio Therapeutics Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Taiwan Bio Therapeutics Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Taiwan Bio Therapeutics Co Ltd Frequently Asked Questions
What is Taiwan Bio Therapeutics Co Ltd(ROCO:6892)'s stock price today?
The current price of ROCO:6892 is NT$43.20. The 52 week high of ROCO:6892 is NT$60.10 and 52 week low is NT$31.00.
When is next earnings date of Taiwan Bio Therapeutics Co Ltd(ROCO:6892)?
The next earnings date of Taiwan Bio Therapeutics Co Ltd(ROCO:6892) is .
Does Taiwan Bio Therapeutics Co Ltd(ROCO:6892) pay dividends? If so, how much?
Taiwan Bio Therapeutics Co Ltd(ROCO:6892) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers